his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment
University of Skövde, School of Health and Education. University of Skövde, Health and Education. Department of Neurobiology, Care Science and Society, Division of Nursing, Karolinska Institutet, Huddinge, Sweden. (Äldre och långvariga hälsoproblem, Health and Ageing)ORCID iD: 0000-0003-0976-531X
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Research and Development Centre, Skaraborg Hospital, Skövde, Sweden.
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Show others and affiliations
2017 (English)In: Supportive Care in Cancer, ISSN 0941-4355, E-ISSN 1433-7339, Vol. 25, no 5, 1423-1429 p.Article in journal (Refereed) Published
Abstract [en]

Purpose

The aim was to prospectively map symptom clusters in patients with stage I–IIIa breast cancer during standard chemotherapy treatment in a randomised study.

Methods

Participants completed the Memorial Symptom Assessment Scale (MSAS) at baseline, day 12 after the first and third cycle of FEC 75 or FEC 100, and day 12 after the last cycle of Taxotere. Cut-off values for symptom scores, a mean value based on each individual reporting a symptom including occurrence, frequency, severity and distress for inclusion in analysis, were determined.

Results

The symptom burden cluster analysis was conducted in two steps and included symptoms with high frequency and high levels of distress. The factor analysis revealed three symptom clusters; physical, gastro (phys/gastro) and emotional, with core symptoms that remained stable over time. The most prevalent symptoms for the total sample during all cycles were as follows: lack of energy (range between 48 and 90%), feeling sad (48–79%), difficulty sleeping (54–78%), difficulty concentrating (53–74%), worrying (54–74%) and pain (29–67%).

Conclusion

In summary, we have prospectively established that symptom clusters remain stable over time with a basis of core symptoms. This knowledge will aid in the development of effective core symptom-focused interventions to minimise symptom burden for patients treated with chemotherapy for breast cancer.

Place, publisher, year, edition, pages
2017. Vol. 25, no 5, 1423-1429 p.
Keyword [en]
Breast cancer, Chemotherapy, Patient reported outcome measures, Symptom, Symptom cluster
National Category
Medical and Health Sciences Nursing
Identifiers
URN: urn:nbn:se:his:diva-13243DOI: 10.1007/s00520-016-3527-1ISI: 000399153200009PubMedID: 27981366Scopus ID: 2-s2.0-85006138053OAI: oai:DiVA.org:his-13243DiVA: diva2:1057608
Available from: 2016-12-19 Created: 2016-12-19 Last updated: 2017-05-05Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Browall, MariaEriksson, Irene
By organisation
School of Health and EducationHealth and Education
In the same journal
Supportive Care in Cancer
Medical and Health SciencesNursing

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 296 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf